Companies: 10,795·Total market cap: $144.5T
Celyad Oncology S.A.

Celyad Oncology S.A.

CYADNASDAQHealthcare
$0.47
$-0.07(-12.96%)
Market Cap$14238462
P/E Ratio—
52W High$3.07
52W Low$0.15
Overview
Foreign Private Issuer · Files 20-F / 6-K

Celyad Oncology S.A. (CYAD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001637890 · CYAD · NASDAQ · as of Jun 9, 2026

Filing snapshot

230
Total Filings
15F-12B
Latest Form
2024-02-09
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001637890 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2023-03-23
Fiscal Year End
Mar 23, 2023
Accession No.
0001193125-23-078009
Primary Document
d418841d20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001637890 · Accession 0001193125-23-078009

Latest Key Filings

6-KQuarterly Report
6-K
2024-01-17
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15F-12B15F-12B
15F-12B
2024-02-09
View
6-KCurrent Report (Foreign Issuer)
6-K
2024-01-17
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-12-21
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-12-18
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-12-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-12-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-11-24
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-11-21
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-11-21
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-11-15
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-10-27
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-09-26
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-09-22
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-09-18
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-09-13
View
Showing 1–15 of 230 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001637890  |  Exchange: NASDAQ · Healthcare

Celyad Oncology S.A. (NASDAQ: CYAD) has submitted 230 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001637890, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Celyad Oncology S.A.'s most comprehensive regulatory disclosure. The most recent Celyad Oncology S.A. 10-K was filed on 2023-03-23 for fiscal year ending 2023. Historical CYAD 10-K annual reports are available from 2015 through 2023.

Investors researching Celyad Oncology S.A. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
HURA SEC Filings →TLPH SEC Filings →REUN SEC Filings →AXLA SEC Filings →GLS SEC Filings →KA SEC Filings →IMNN SEC Filings →NTBL SEC Filings →
→ CYAD Financials→ CYAD Earnings→ CYAD Insider Trades

Frequently Asked Questions

CYAD SEC Filings · 8 questions

Celyad Oncology S.A. (CYAD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 230 filings and access original documents at no cost. Celyad Oncology S.A.'s CIK is 0001637890.

CYAD SEC filingsCelyad Oncology S.A. SEC documentsfind CYAD 10-K